Pvolve's recent partnership with Weight Watchers is highly important for the fitness industry amid the rise of GLP-1s.
Weight Watchers is the latest telehealth company to bundle pharma and fitness, a model that's quickly becoming the industry standard.
This year's Super Bowl LX ad slate shows just how much has changed in the conversation around health and wellness.
New data from Noom suggests that people who put more effort into eating healthy and working out see the best results from weight-loss drugs.
From functional beverages to GLP-1 nutrition strategies, experts say fiber is poised to overtake (or at least equal) protein in popular importance.
GLP-1s deliver dramatic weight loss, but a new study reveals what happens when treatment stops and why weight often comes back fast.
Experts from at-home testing and nutrition company Zoe shared where they see industry trends going, for better or worse, in 2026.
Weight loss is a top priority for Americans amid the rise of GLP-1s, but rising emotional strain suggests the system is starting to crack
The new Weight Watchers app combines GLP-1 prescriptions with personalized nutrition tools, coaching and strength training offerings.
Noom’s microdose GLP-1 program targets early metabolic risk and longevity, offering weight-loss drugs to adults with a BMI of 21 or higher.
Sign Up to Our Newsletter
